Evaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India: a prospective study (original) (raw)

AI-generated Abstract

Drug-related events (DREs) are a significant cause of hospital admissions, with this study evaluating the cost of treatment for DREs in a tertiary care public sector hospital in Northern India. Over four months, 92 out of 1833 admissions were related to DREs, primarily due to non-compliance, adverse drug reactions, and drug overdoses. The total cost of managing these DREs was approximately INR 17,37,339 (about €30,215), with direct costs accounting for INR 1,72,961 (about €3008) and indirect costs around INR 15,64,378 (about €27,206). In contrast, the projected cost for the same DREs in a private sector hospital was estimated at nearly four times higher at INR 63,63,872 (about €1,01,676). This study highlights the economic burden of DREs on the healthcare system and underscores the importance of patient education.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (22)

  1. Helper CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-43.
  2. Strand LM, Morley PC, Cipolle RJ, Ramsay R, Lasman GD. Drug related problems: their structure and function. Drug Intell Clin Pharm 1990; 24: 1093-7.
  3. Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N, Petersen LA, Small S, Sweitzer B, Vliet MV, Leape LL. Patient risk factors for adverse drug events in hospitalized patients. Arch Intern Med 1999; 159: 2553-60.
  4. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N. The cost of adverse drug events in hospitalized patients. J Am Med Assoc 1997; 277: 307-11.
  5. Ayani I, Aguirre C, Gutiérrez G, Madariaga A, Rodríguez-Sasiaín JM, Martínez-Bengoechea MJ. A cost-analysis of suspected adverse drug reactions in a hospital emergency ward. Pharmacoepidemiol Drug Saf 1999; 8: 529-34.
  6. White TJ, Arakelian A, Rho JP. Counting cost of drug related adverse events. Pharmacoeconomics 1999; 15: 445-58.
  7. Gautier S, Bachelet H, Bordet R, Caron J. The cost of adverse drug reactions. Expert Opin Pharmacother 2003; 4: 319-26.
  8. Dartnell JG, Anderson RP, Chohan V. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996; 164: 659-62.
  9. 9 Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol 2007; 7: 8.
  10. Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring -cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf 1997; 6 (Suppl. 3): S79-90.
  11. Johnson JA, Bootman JL. Drug related morbidity and mortality: a cost of illness model. Arch Intern Med 1995; 155: 1949-56.
  12. Sullivan JW. A pharmaceutical manufacturer's perspective on reporting adverse drug experiences. Am J Hosp Pharm 1990; 47: 1342-5.
  13. Beringer PM, Wong-Beringer A, Rho JP. Economic aspects of antibacterial adverse effects. Pharmacoeconomics 1998; 13: 35-49.
  14. Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol 2004; 18: 275-80.
  15. World Health Organization. Intensive Drug Monitoring: the Role of National Centers. WHO technical report series No 498. Geneva: World Health Organization, 1972.
  16. Col N, Fanale JE, Kronholm P. The role of medication non-compliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841-5.
  17. Laurence DR, Bennett PN, Brown MJ. Clinical Pharmacology, 8th edn. London: Churchill Livingstone, 1997.
  18. Stockly IH. Drug Ineractions, 3rd edn. Oxford: Blackwell Scientific Publications, 1994.
  19. Debroy B. What is India's per capita income? Oct 15, 2005. Available at http://in.rediff.com/money/2005/oct/ 13income.htm (last accessed 15 January 2008).
  20. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital -their severity and cost involved. Pharmacoepidemiol Drug Saf 2003; 12: 687-92.
  21. Arulmani R, Rajendran SD, Suresh B. Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol 2007; 65: 210-6.
  22. Malhotra S, Jain S, Pandhi P. Drug-related visits to the medical emergency department: a prospective study from India. Int J Clin Pharmacol Ther 2001; 39: 12-8.